Seeing Is Believing
Currently, out of the existing stock ratings of Jason Butler - 194 which are a Buy (94.63%), 11 which are a Hold (5.37%)
Analyst Jason Butler works at JMP and is covering Healthcare, Industrials sectors with 406 price targets and ratings displayed on 39 stocks.
Jason Butler's average stock forecast success ratio is 29.53% with an average time for price targets to be met of 161.74 days.
Most recent stock forecast was given on AQST, Aquestive Therapeutics at 21-Sep-2023.
Analyst best performing recommendations are on TRVN (TREVENA).
The best stock recommendation documented was for TRVN (TREVENA) at 3/31/2023. The price target of $2 was fulfilled within 38 days with a profit of $1.3 (185.71%) receiving and performance score of 48.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
30
$4.42 (17.28%)
30
1 months 25 days ago
14/20 (70%)
$6 (20.78%)
165
Buy
38
$12.42 (48.55%)
26
1 months 25 days ago
15/18 (83.33%)
$7.65 (27.96%)
182
Buy
33
$7.42 (29.01%)
33
1 months 25 days ago
9/13 (69.23%)
$8.33 (34.09%)
122
Hold
25
$-0.58 (-2.27%)
25
1 months 25 days ago
10/12 (83.33%)
$-0.47 (0.44%)
40
Buy
33
$7.42 (29.01%)
27
2 months 14 days ago
10/16 (62.5%)
$9.2 (38.05%)
224
Which stock is Jason Butler is most bullish on?
Which stock is Jason Butler is most reserved on?
What Year was the first public recommendation made by Jason Butler?